Brooks Laboratories Ltd (BROOKS) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 539063, "name": "Brooks Lab.", "stock_name": "Brooks Lab.", "full_name": "Brooks Laboratories Ltd", "name_url": "stocks-analysis/brooks-lab", "exchange": 1, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "60.19", "chg": 0.79, "chgp": "1.33%", "dir": 1, "prev_price": "59.40", "mcapval": "177.30 Cr", "mcap": "Micro Cap", "scripcode": 533543, "symbol": "BROOKS", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE650L01011", "curr_date": "Sep 25, 01:15 PM", "curr_time": "13:35 PM", "last_traded_at": "Sep 25, 01:15 PM IST", "bse_nse_vol": "16.93 k", "exc_status": "Active", "traded_date": "Sep 25, 2026", "traded_date_str": "2026 09 25", "score": "", "scoreText": "", "Live": 0, "market_time": 1, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/brooks-lab-539063-1&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Brooks Laboratories Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/brooks-laboratories-ltd-is-rated-strong-sell-4204825", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BrooksLaborator_mojoScore_4204825.png", "date": "2026-09-25 10:10:42", "description": "Brooks Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 August 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 25 September 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Brooks Laboratories Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/brooks-laboratories-ltd-is-rated-strong-sell-4192368", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BrooksLaborator_mojoScore_4192368.png", "date": "2026-09-14 10:10:46", "description": "Brooks Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 September 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Brooks Laboratories Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/brooks-laboratories-ltd-is-rated-strong-sell-4179344", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BrooksLaborator_mojoScore_4179344.png", "date": "2026-09-02 10:11:11", "description": "Brooks Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 August 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 02 September 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Brooks Laboratories Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent", "link": "https://www.marketsmojo.com/news/stocks-in-action/brooks-laboratories-ltd-hits-upper-circuit-amid-strong-buying-momentum-4173579", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BrooksLaborator_stocks_hitting_upper_circuit_4173579.png", "date": "2026-08-28 12:00:07", "description": "At Rs 69.28, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Brooks Laboratories Ltd locked at its upper circuit of 4.99% on 28 Aug 2026, with buyers queuing and no sellers willing to part with shares." }, { "title": "Brooks Laboratories Ltd Locks at Upper Circuit With 5.0% Gain — Buyers Queue, Sellers Absent", "link": "https://www.marketsmojo.com/news/stocks-in-action/brooks-laboratories-ltd-hits-upper-circuit-amid-strong-buying-pressure-4171660", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BrooksLaborator_stocks_hitting_upper_circuit_4171660.png", "date": "2026-08-27 11:00:07", "description": "At Rs 65.99, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Brooks Laboratories Ltd locked at its upper circuit of 5.0% on 27 Aug 2026, with buyers queuing and no sellers willing to part with shares." }, { "title": "Brooks Laboratories Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/brooks-laboratories-ltd-is-rated-strong-sell-4164802", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BrooksLaborator_mojoScore_4164802.png", "date": "2026-08-22 10:10:39", "description": "Brooks Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 August 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 22 August 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Brooks Laboratories Gains 3.29%: 5 Key Factors Driving the Week’s Volatility", "link": "https://www.marketsmojo.com/news/stocks-in-action/brooks-laboratories-gains-329-5-key-factors-driving-the-weeks-volatility-4155915", "imagepath": "", "date": "2026-08-15 17:02:19", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>10 Aug:</strong> Mojo Grade upgraded from Strong Sell to Sell</p>\n <p><strong>12 Aug:</strong> Stock hits upper circuit with 4.94% gain</p>\n <p><strong>13 Aug:</strong> Another upper circuit hit, gaining 4.99%</p>\n <p><strong>14 Aug:</strong> Reports negative quarterly financial trend</p>\n <p><strong>14 Aug:</strong> Stock plunges to lower circuit, down 5.0%</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.60.85</div></div>\n <div class=\"stat-item\"><div class=\"st..." }, { "title": "Below All Moving Averages and Now at Lower Circuit: Brooks Laboratories Ltd Loses 5.0% in a Single Session", "link": "https://www.marketsmojo.com/news/stocks-in-action/brooks-laboratories-ltd-plunges-to-lower-circuit-amid-heavy-selling-pressure-4153826", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BrooksLaborator_stocks_hitting_lower_circuit_4153826.png", "date": "2026-08-14 14:00:08", "description": "At Rs 62.32, sellers were still queuing — but there were no buyers willing to take the other side. Brooks Laboratories Ltd locked at its lower circuit of 5.0% on 14 Aug 2026, with unfilled sell orders and a frozen price, signalling a pronounced imbalance in supply and demand." }, { "title": "Brooks Laboratories Ltd Reports Negative Quarterly Financial Trend Amid Margin Pressures", "link": "https://www.marketsmojo.com/news/stocks-in-action/brooks-laboratories-ltd-reports-negative-quarterly-financial-trend-amid-margin-pressures-4153724", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BrooksLaborator_fintrenddot_4153724.png", "date": "2026-08-14 12:00:16", "description": "Brooks Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has reported a marked deterioration in its financial performance for the quarter ended June 2026. The company’s financial trend has shifted from flat to negative, with key profitability metrics plunging and the stock price reflecting investor concerns amid broader market pressures." } ], "total": 354, "sid": "539063", "stock_news_url": "https://www.marketsmojo.com/news/brooks-laboratories-539063" }, "announcements": [ { "details": "Brooks Laboratories Limited has informed the Exchange regarding Disclosure of Related Party Transactions for the half year ended September 30, 2019.", "source": "NSE", "caption": "Brooks Laboratories Limited - Other General Purpose", "datetime": "09-Dec-2019" }, { "details": "Brooks Laboratories Limited has informed the Exchange regarding a press release dated November 15, 2019, titled \"Unaudited Financial Results for the 2nd quarter and half year ended 30.09.2019\".", "source": "NSE", "caption": "Brooks Laboratories Limited - Press Release", "datetime": "15-Nov-2019" }, { "details": "Brooks Laboratories Limited has informed the Exchange regarding Reappointment of Auditor of the company.", "source": "NSE", "caption": "Brooks Laboratories Limited - Reappointment", "datetime": "25-Sep-2019" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "", "data": [ { "txt": "Brooks Laboratories Ltd has announced <strong>1:16</strong> rights issue, ex-date: 28 Jul 23", "dt": "2023-07-28", "middle_text": "Rights Issue" } ] } ] }

Key Events This Week

10 Aug: Mojo Grade upgraded from Strong Sell to Sell

12 Aug: Stock hits upper circuit with 4.94% gain

13 Aug: Another upper circuit hit, gaining 4.99%

14 Aug: Reports negative quarterly financial trend

14 Aug: Stock plunges to lower circuit, down 5.0%

Week Open

Rs.60.85

Read full news article

Below All Moving Averages and Now at Lower Circuit: Brooks Laboratories Ltd Loses 5.0% in a Single Session

2026-08-14 14:00:08

At Rs 62.32, sellers were still queuing — but there were no buyers willing to take the other side. Brooks Laboratories Ltd locked at its lower circuit of 5.0% on 14 Aug 2026, with unfilled sell orders and a frozen price, signalling a pronounced imbalance in supply and demand.

Read full news article

Brooks Laboratories Ltd Reports Negative Quarterly Financial Trend Amid Margin Pressures

2026-08-14 12:00:16

Brooks Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has reported a marked deterioration in its financial performance for the quarter ended June 2026. The company’s financial trend has shifted from flat to negative, with key profitability metrics plunging and the stock price reflecting investor concerns amid broader market pressures.

Read full news article